Vishwajit L. Nimgaonkar

Vishwajit L. Nimgaonkar

Auto-generated profile, based on publicly available information

Vishwajit L. Nimgaonkar

Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O’Hara Street, Pittsburgh, PA 15213, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2005 in Genes, Brain and Behavior
Verified
Journal Article
Open access
PDF file
HMH. A. Mansour
H. A. Mansour
JWJ. Wood
J. Wood
TLT. Logue
T. Logue
KCK. V. Chowdari
K. V. Chowdari
MDM. Dayal
M. Dayal
VNV. L. Nimgaonkar
V. L. Nimgaonkar
We hypothesize that circadian dysfunction could underlie, at least partially, the liability for bipolar 1 disorder (BD1). Our hypothesis motivated tests for the association between the polymorphisms of genes that mediate circadian function and liability for BD1. The US Caucasian patients with BD1 (DSM‐IV criteria) and available parents were recruited from Pittsburgh and surrounding areas (n = 138 cases, 196 parents) and also selected from the NIMH Genetics Collaborative Initiative (n = 96 cases, 192 parents). We assayed 44 informative single‐nucleotide polymorphisms (SNPs) from eight circadian genes in the BD1 samples. A population‐based sample, specifically cord blood samples from local live births, served as community‐based controls (n = 180). It was used as a contrast for genotype and haplotype distributions with those of patients. US patients with schizophrenia/schizoaffective disorder (SZ/SZA, n = 331) and available parents from Pittsburgh (n = 344) were assayed for a smaller set of SNPs based on the results from the BD1 samples. Modest associations with SNPs at ARNTL (BmaL1) and TIMELESS genes were observed in the BD1 samples. The associations were detected using family‐based and case–control analyses, albeit with different SNPs. Associations with TIMELESS and PERIOD3 were also detected in the Pittsburgh SZ/SZA group. Thus far, evidence for association between specific SNPs at the circadian gene loci and BD1 is tentative. Additional studies using larger samples are required to evaluate the associations reported here.

1 April 2009 in Psychiatry Research
Verified
Journal Article
Closed access
JWJoel Wood
Joel Wood
BBBoris Birmaher
Boris Birmaher
DADavid Axelson
David Axelson
MEMary Ehmann
Mary Ehmann
CKCatherine Kalas
Catherine Kalas
VNVishwajit L. Nimgainkar
Vishwajit L. Nimgainkar

23 June 2014 in International Journal of Social Psychiatry
Verified
Journal Article
Closed access
PDF file
ASAhmed M Sewilam
Ahmed M Sewilam
AWAnnie Mm Watson
Annie Mm Watson
AKAhmed M Kassem
Ahmed M Kassem
SCSue Clifton
Sue Clifton
MMMargaret C McDonald
Margaret C McDonald
VNVishwajit L Nimgaonkar
Vishwajit L Nimgaonkar
Background: Stigma toward mentally ill individuals acts as a barrier to accessing care and receiving treatment. Aim: To review current evidence pertaining to stigma toward mental illness in the Middle East in order to inform effective and sustainable interventions in this region. Methods: We conducted a systematic literature search using the PubMed database and evaluated all identified studies according to specific inclusion criteria. Results: Stigma toward individuals with mental illness does exist in the Middle East. Stigmatizing attitudes are particularly high toward culturally proscribed mental illnesses like alcohol abuse and lower for other disorders such as depression and psychosis. Conclusions: We propose the following initiatives to reduce stigma toward mental illness in the Middle East: (a) educate families to enable them to support their affected relatives, (b) increase cooperation between psychiatrists and faith healers and (c) educate young people in schools to increase their awareness and understanding of mental illnesses and to combat negative stereotypes.

2 October 2014 in Organogenesis
Verified
Journal Article
Closed access
LDLeonardo D’aIuto
Leonardo D’aIuto
YZYun Zhi
Yun Zhi
DDDhanjit Kumar Das
Dhanjit Kumar Das
MWMadeleine R Wilcox
Madeleine R Wilcox
JJJon W Johnson
Jon W Johnson
VNVishwajit L Nimgaonka
Vishwajit L Nimgaonka
Induced pluripotent stem cell (iPSC)-based technologies offer an unprecedented opportunity to perform high-throughput screening of novel drugs for neurological and neurodegenerative diseases. Such screenings require a robust and scalable method for generating large numbers of mature, differentiated neuronal cells. Currently available methods based on differentiation of embryoid bodies (EBs) or directed differentiation of adherent culture systems are either expensive or are not scalable. We developed a protocol for large-scale generation of neuronal stem cells (NSCs)/early neural progenitor cells (eNPCs) and their differentiation into neurons. Our scalable protocol allows robust and cost-effective generation of NSCs/eNPCs from iPSCs. Following culture in neurobasal medium supplemented with B27 and BDNF, NSCs/eNPCs differentiate predominantly into vesicular glutamate transporter 1 (VGLUT1) positive neurons. Targeted mass spectrometry analysis demonstrates that iPSC-derived neurons express ligand-gated channels and other synaptic proteins and whole-cell patch-clamp experiments indicate that these channels are functional. The robust and cost-effective differentiation protocol described here for large-scale generation of NSCs/eNPCs and their differentiation into neurons paves the way for automated high-throughput screening of drugs for neurological and neurodegenerative diseases.

1 August 2017 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
VNV L Nimgaonkar
V L Nimgaonkar
KPK M Prasad
K M Prasad
KCK V Chowdari
K V Chowdari
ESE G Severance
E G Severance
RYR H Yolken
R H Yolken
The pathogenesis of schizophrenia is considered to be multi-factorial, with likely gene–environment interactions (GEI). Genetic and environmental risk factors are being identified with increasing frequency, yet their very number vastly increases the scope of possible GEI, making it difficult to identify them with certainty. Accumulating evidence suggests a dysregulated complement pathway among the pathogenic processes of schizophrenia. The complement pathway mediates innate and acquired immunity, and its activation drives the removal of damaged cells, autoantigens and environmentally derived antigens. Abnormalities in complement functions occur in many infectious and autoimmune disorders that have been linked to schizophrenia. Many older reports indicate altered serum complement activity in schizophrenia, though the data are inconclusive. Compellingly, recent genome-wide association studies suggest repeat polymorphisms incorporating the complement 4A (C4A) and 4B (C4B) genes as risk factors for schizophrenia. The C4A/C4B genetic associations have re-ignited interest not only in inflammation-related models for schizophrenia pathogenesis, but also in neurodevelopmental theories, because rodent models indicate a role for complement proteins in synaptic pruning and neurodevelopment. Thus, the complement system could be used as one of the ‘staging posts’ for a variety of focused studies of schizophrenia pathogenesis. They include GEI studies of the C4A/C4B repeat polymorphisms in relation to inflammation-related or infectious processes, animal model studies and tests of hypotheses linked to autoimmune diseases that can co-segregate with schizophrenia. If they can be replicated, such studies would vastly improve our understanding of pathogenic processes in schizophrenia through GEI analyses and open new avenues for therapy.

1 July 2016 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Closed access
VNVishwajit L. Nimgaonkar
Vishwajit L. Nimgaonkar
RYRobert H. Yolken
Robert H. Yolken
TWTianxiu Wang
Tianxiu Wang
CCChung-Chou H. Chang
Chung-Chou H. Chang
LMLora BS McClain
Lora BS McClain
MGMary Ganguli
Mary Ganguli
Background: Numerous cross-sectional studies have related exposure to neurotropic infectious agents with cognitive dysfunction in older adults, however, the temporal sequence is uncertain. Methods: In a representative, well-characterized, population-based aging cohort, we determined whether the temporal trajectories of multiple cognitive domains are associated with exposure to cytomegalovirus (CMV), Herpes Simplex virus, type 1 (HSV-1), Herpes Simplex virus, type 2 (HSV-2), or Toxoplasma gondii (TOX). Complex attention, executive functions, memory, language, and visuospatial function were assessed annually for 5 years among consenting individuals. Study entry IgG antibody titers indexing exposure to each infectious agent were examined in relation to slopes of subsequent temporal cognitive decline using multiple linear regressions adjusted for potential confounders. Results: The IgG levels for HSV-2 were significantly associated with baseline cognitive domain scores (N=1022 participants). Further, the IgG levels for HSV-2, TOX, and CMV, but not HSV-1 were significantly associated with greater temporal cognitive decline that varied by type of infection. Conclusions: Exposure to CMV, HSV-2, or TOX is associated with cognitive deterioration in older individuals, independent of general age–related variables. An increased understanding of the role of infectious agents in cognitive decline may lead to new methods for its prevention and treatment.